<DOC>
	<DOCNO>NCT00185224</DOCNO>
	<brief_summary>The purpose study confirm safety SH T00658ID regard plasma lipid , hemostatic variable , carbohydrate metabolism . In addition , pharmacokinetic parameter follow long term administration SH T00658ID assess .</brief_summary>
	<brief_title>Metabolism Study Investigate Impact Sequential Oral Contraceptive</brief_title>
	<detailed_description>The study previously post Schering AG , Germany . Schering AG , Germany rename Bayer Schering Pharma AG , Germany.Bayer Schering Pharma AG , Germany sponsor trial .</detailed_description>
	<mesh_term>Contraceptives , Oral</mesh_term>
	<mesh_term>Ethinyl Estradiol-Norgestrel Combination</mesh_term>
	<mesh_term>Contraceptive Agents</mesh_term>
	<mesh_term>Contraceptives , Oral , Sequential</mesh_term>
	<criteria>Healthy female volunteer 18 50 year require contraception Pregnancy lactation Any condition might interfere outcome well contraindication OC use</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>July 2011</verification_date>
</DOC>